The DOI matches its Crossref record; 227 of the 230 references it cites were found in a registry or an index.
From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD
Open accessAbstract
Stimulants represent the first line pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD) and are among the most prescribed psychopharmacological treatments. Their mechanism of action at synaptic level has been extensively studied. However, it is less clear how their mechanism of action determines clinically observed benefits. To help bridge this gap, we provide a comprehensive review of stimulant effects, with an emphasis on nuclear medicine and magnetic resonance imaging (MRI) findings. There is evidence that stimulant-induced modulation of dopamine and norepinephrine neurotransmission optimizes engagement of task-related brain networks, increases perceived saliency, and reduces interference from the default mode network. An acute administration of stimulants may reduce brain alterations observed in untreated individuals in fronto-striato-parieto-cerebellar networks during tasks or at rest. Potential effects of prolonged treatment remain controversial. Overall, neuroimaging has fostered understanding on stimulant mechanism of action. However, studies are often limited by small samples, short or no follow-up, and methodological heterogeneity. Future studies should address age-related and longer-term effects, potential differences among stimulants, and predictors of treatment response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies using acute administration of stimulants demonstrated that neural activity in adults with ADHD can be modulated towards similar levels as those of adults without ADHD in various tasks (Parlatini et al., 2024).”
From Are prediction error modifications domain specific in autism but domain general in ADHD? (2025) · cites this paper as Parlatini et al., 2024
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–227 of 227
Nikolaus, S., Mamlins, E., Giesel, F. L., Schmitt, D. R., & Müller, H. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0083 · Cited by 19
Mizuno, Y., Cai, W., Supekar, K., Makita, K., Takiguchi, S., Silk, T. J., Tomoda, A., & Menon, V. (2022) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2022.10.001 · Cited by 18
Cerebellar network alterations in adult attention-deficit/hyperactivity disorder
Parkkinen, S., Raduà, J., Andrews, D. S., Murphy, D., Dell’Acqua, F., & Parlatini, V. (2024) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.230146 · Cited by 18
Self-citationKowalczyk, O. S., Cubillo, A. I., Criaud, M., Giampietro, V., O’Daly, O., Mehta, M. A., & Rubia, K. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06422-7 · Cited by 17
Mamiya, P. C., Richards, T. L., Edden, R. A. E., Lee, A. K. C., Stein, M. A., & Kuhl, P. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094677 · Cited by 15
Boerner, T., Bygrave, A. M., Chen, J., Fernando, A. B. P., Jackson, S., Barkus, C., Sprengel, R., Seeburg, P. H., Harrison, P. J., Gilmour, G., et al. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13539 · Cited by 14
Fu, Z., Yuan, J., Pei, X., Zhang, K., Xu, C., Hu, N., Xie, R., Zhao, Y., Wang, Y., Yang, L., et al. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac028 · Cited by 14
Fernández, L., Burmester, A., Duque, J. D., Silk, T. J., Hyde, C. E., Kirkovski, M., Enticott, P. G., & Caeyenberghs, K. (2022) · The Cerebellum · doi:10.1007/s12311-022-01503-3 · Cited by 14
Park, S., Kim, B.-N., Kim, J.-W., Shin, M., Cho, S.-C., Kim, J.-H., Son, J.-W., Shin, Y., Chung, U., & Han, D. H. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113480989 · Cited by 13
Nguyen, H., Cheng, M. H., Lee, J. Y., Aggarwal, S., Mortensen, O. V., & Bahar, İ. (2024) · Current Research in Physiology · doi:10.1016/j.crphys.2024.100125 · Cited by 13
Nahavandi, A. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.07.2403 · Cited by 12
Schweren, L., Groenman, A. P., von Rhein, D. T., Weeda, W. D., Faraone, S. V., Luman, M., van Ewijk, H., Heslenfeld, D. J., Franke, B., Buitelaar, J. K., et al. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10624 · Cited by 12
Cai, W., Mizuno, Y., Tomoda, A., & Menon, V. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01668-3 · Cited by 12
Chen, Z., Xu, T., Liu, X., Becker, B., Li, W., Miao, K., Gong, Z., Zhang, R., Huo, Z., Hu, B., et al. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13649 · Cited by 11
Schulz, K. P., Krone, B., Adler, L. A., Bedard, A., Duhoux, S., Pedraza, J. D., Mahagabin, S., & Newcorn, J. H. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.03.004 · Cited by 10
Ulrich, M., Heckel, K., Kölle, M. A., & Grön, G. (2022) · Biology · doi:10.3390/biology11091320 · Cited by 10
Shang, C., Chou, T., Hsieh, C.-Y., & Gau, S. S. (2022) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2022.0024 · Cited by 10
Cortical alterations associated with lower response to methylphenidate in adults with ADHD
Parlatini, V., Andrews, D. S., Pretzsch, C. M., Arenella, M., Daly, E., Ecker, C., & Murphy, D. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00228-y · Cited by 9
Self-citationEl‐Saied, M. M., Afify, O. G. E., Raouf, E. R. A., Oraby, A., Hashish, A. F., & Zeidan, H. M. (2024) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10332 · Cited by 9
¿Cómo afecta el metilfenidato al circuito de activación por defecto? Revisión sistemática
Junior, P. S. M. D. S., Gonçalves, R., & Pedroso, S. (2019) · Revista de Neurología · doi:10.33588/rn.6810.2018487 · Cited by 8
Aster, H.-C., Romanos, M., Walitza, S., Gerlach, M., Mühlberger, A., Rizzo, A., Andreatta, M., Hasenauer, N., Hartrampf, P. E., Nerlich, K., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.804730 · Cited by 8
Akay, A. P., Kaya, G. Ç., Köse, S., Yazıcıoğlu, Ç. E., Erkuran, H. Ö., Güney, S. A., Oğuz, K., Keskin, D., Baykara, B., İnal, N., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.008 · Cited by 7
Newcorn, J. H., Ivanov, I., Krone, B., Li, X., Duhoux, S., White, S., Schulz, K. P., Bédard, A.-C. V., Pedraza, J., Adler, L., et al. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.11.037 · Cited by 7
Positron emission tomography studies in adult patients with attention-deficit/hyperactivity disorder
Yamamoto, M., & Inada, T. (2022) · Japanese Journal of Radiology · doi:10.1007/s11604-022-01368-w · Cited by 6
Rode, J., Runnamo, R., Thunberg, P., & Msghina, M. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.05.073 · Cited by 6
Vidor, M. V., Vitola, E. S., Bandeira, C. E., Martins, A. R., Tavares, M. E., Cupertino, R. B., Panzenhagen, A. C., da Silva, B. S., Falkenberg, I. G., Barreto, P. O., et al. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01805-z · Cited by 4
Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine
Newcorn, J. H. (2018) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.09.012 · Cited by 2
Flagged first, then by citations
3 of the 230 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Parlatini, 2023, White matter alterations in Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review of 129 diffusion imaging studies with meta-analysis, Mol. Psychiatry, 10.1038/s41380-023-02173-1 · DOI
- Parlatini, 2024, A state-of-the-art overview of candidate diagnostic biomarkers for Attention-deficit/hyperactivity disorder (ADHD), Expert Rev. Mol. Diagn., 24, 259, 10.1080/14737159.2024.2333277 · DOI
Cited by
Sorted by citations
MacDonald, H. J., Kleppe, R., Szigetvari, P. D., & Haavik, J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1492126 · Cited by 124
Zheng, P., Zheng, X., Chen, Q., Wang, D., Huang, L., Lin, J., & Chen, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-17182-z · Cited by 7
Plasmon-enhanced fluorescence sensor based on Au nanocages for sensitive detection of norepinephrine
Xu, C., Chen, S., Sun, W., Xu, R., Yin, X., Guo, D., & Yang, Y. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.343995 · Cited by 7
Pretzsch, C. M., Parlatini, V., & Murphy, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-87204-3 · Cited by 9
Self-citationBesag, F., Vasey, M. J., Roy, S., & Cortese, S. (2025) · CNS Drugs · doi:10.1007/s40263-024-01154-4 · Cited by 8
Self-citation
Metadata
- Authors
- Parlatini, V., Bellato, A., Murphy, D., & Cortese, S.
- Affiliations
- King's College London (GB)
- University of Nottingham (GB)
- Corresponding author
- Parlatini, Valeria
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2024-09
- Volume
- 164
- Pages
- 105841
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W4401306218
- Cited by
- 26
- References
- 230
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 1
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Neuroscience & Biobehavioral Reviews (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- iMinds
- British Association for Psychopharmacology
- Aims2Cure (AIMS-2-TRIALS, 115300, 777394)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- attention deficit hyperactivity disorder, stimulant medication, pharmacodynamics, dopamine signaling, brain networks, default mode network, salience, long-term treatment outcomes, predictors of treatment response
- MeSH terms
- Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Brain, Humans, Nerve Net, Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
